C84.76
Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma, a cancer that begins in the lymphatic system. The subtype characterized as ALK-negative is distinguished by the absence of anaplastic lymphoma kinase gene rearrangements. When this lymphoma involves the intrapelvic lymph nodes, it can affect the pelvic region within the abdomen. Understanding this condition involves exploring its causes, symptoms, diagnosis, and treatment options, providing a comprehensive overview for patients and their loved ones.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal cell growth in lymphocytes Certain infections that may influence immune system behavior Previous exposure to radiation or certain chemicals Suppressed immune system conditions, such as HIV/AIDS or post-transplant immunosuppression
Key Symptoms: Swelling or painless lumps in the pelvic area or groin Unexplained weight loss Persistent fatigue and weakness Fever and night sweats Discomfort or pain in the pelvic region Frequent infections or unusual infections due to immune system impact
Diagnostic & Treatment
Diagnosis Path: Diagnosing anaplastic large cell lymphoma involving intrapelvic lymph nodes typically involves a combination of clinical examinations and diagnostic tests, such as: - Physical assessment and medical history review - Imaging studies like CT scans, PET scans, or MRI to visualize lymph node involvement - Biopsy of the affected lymph nodes to examine cells microscopically - Immunohistochemistry tests to detect specific markers, including ALK status - Bone marrow biopsy if systemic spread is suspected The confirmation of ALK-negative status is crucial as it influences prognosis and treatment planning.
Treatment Protocols: Treatment strategies for ALK-negative anaplastic large cell lymphoma depend on the extent of disease and overall health. Common approaches include: - Chemotherapy regimens tailored to lymphoma types - Targeted therapies, if available and appropriate - Radiation therapy to affected nodes - Stem cell transplantation in selected cases - Supportive care to manage symptoms and improve quality of life Advances in lymphoma treatments continue to enhance outcomes, but the specific course of therapy should always be discussed with a healthcare professional familiar with the patient's condition.
Clinical Advice & FAQs
Billing Guidance
Is C84.76 a billable ICD-10 code?
Yes, C84.76 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.76?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference